CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
26.09
-0.40 (-1.53%)
Aug 14, 2025, 11:46 AM - Market open

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,9892,183---
Enterprise Value
1,3601,643---
Last Close Price
26.4928.68---
PS Ratio
3665.701916.94---
PB Ratio
3.012.98---
P/TBV Ratio
3.012.98---
EV/Sales Ratio
2467.771442.48---
Debt / Equity Ratio
0.0000.000.130.38
Asset Turnover
-0.000.000.00-
Quick Ratio
21.7834.7613.179.328.97
Current Ratio
22.1535.3013.629.549.78
Return on Equity (ROE)
--19.18%-31.36%-42.85%-
Return on Assets (ROA)
--15.02%-19.97%-21.34%-
Return on Capital (ROIC)
--15.60%-21.24%-22.42%-
Earnings Yield
-6.34%-4.03%---
FCF Yield
-4.66%-3.62%---
Buyback Yield / Dilution
-376.91%-1343.03%-15.77%-2.48%-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q